The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.

Weight loss jabs such as Wegovy and Mounjaro could be handed out “on the high street, or at any out-of-two shopping centre”, ...

A PIL has claimed that licences for these drugs were issued without adequate data or India-specific trials and studies, ...

As weight-loss injections like Mounjaro and Wegovy soar in popularity across the UK, jewellers say they’re seeing an unexpected side effect: wedding and engagement rings no longer fit, and in they are ...

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

They burst onto the scene four years ago and are taking over the pharmaceutical world. New GLP-1-based drugs like Ozempic, Wegovy or Zepbound are said to be a weight-loss game changer and could drive ...

As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised ...

The British drug agency is monitoring a possible increase in cases of the disease, although there is no data yet to warrant ...

Weight loss drugs can’t replace the power of group support for lasting weight loss, says local expert A Slimming World ...

Just two days after Novo Nordisk launched Wegovy (semaglutide 2.4 mg) in India, Eli Lilly received regulatory approval for the KwikPen® format of its rival therapy Mounjaro (tirzepatide) ...

Hamish FitzSimons and Dougal Maple-Brown apply their respective lenses to 5 ASX stocks with strong balance sheets.